Filing Flows › Intelligent Bio Solutions (INBS) › Q3 FY26 › vs Q3 FY25
Intelligent Bio Solutions (INBS) Q3 FY26 vs Q3 FY25 (year over year)
Intelligent Bio Solutions's revenue rose $159K (+18%) from $902K in Q3 FY25 to $1.1M in Q3 FY26. The biggest changes: Sales of goods - cartridges +$262K (+59%); Other sales - accessories +$97K (+80%); Sales of goods - readers −$26K (-16%).
Intelligent Bio Solutions, Q3 FY26: revenue $1.1M (+18% year over year), operating margin -277.8%, net loss $2.9M, operating cash flow −$4.3M. The chart draws each line against Q3 FY25, the increases inside each band.
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Sales of goods - cartridges | $704K | $442K | $262K | +59% |
| Other sales - accessories | $218K | $121K | $97K | +80% |
| Sales of goods - readers | $139K | $166K | −$26K | -16% |
| Revenue | $1.1M | $902K | $159K | +18% |
| Other income, net | $77K | $10K | $68K | +702% |
| Net loss | $2.9M | $2.6M | $319K | +13% |
| Costs & expenses | $4.0M | $3.5M | $545K | +16% |
| Operating costs | $4.0M | $3.5M | $545K | +16% |
| Cost of revenue | $525K | $561K | −$35K | -6% |
| SG&A | $2.5M | $2.4M | $44K | +2% |
| Other operating costs | $1.0M | $487K | $537K | +110% |
| Operating cash sources | $4.6M | $2.9M | $1.8M | +61% |
| Depreciation & amortization | $290K | $115K | $175K | +152% |
| Share-based compensation | $24K | $12K | $12K | +102% |
| Cash used in operations | $4.3M | $2.8M | $1.6M | +57% |
| Net loss absorbed | $2.9M | $2.6M | $319K | +13% |
| Working capital & other | $1.8M | $332K | $1.4M | +435% |
Questions
How much did Intelligent Bio Solutions's revenue grow year over year in Q3 FY26?
Intelligent Bio Solutions's revenue rose $159K (+18%) from $902K in Q3 FY25 to $1.1M in Q3 FY26.
What drove Intelligent Bio Solutions's revenue change in Q3 FY26?
Sales of goods - cartridges +$262K (+59%); Other sales - accessories +$97K (+80%); Sales of goods - readers −$26K (-16%).